| | 
Part, Chapter, Paragraph
1 I, 2. 11 | Perspectives, 115(1), 5-12~Suhrcke M, McKee M, Sauto Arce R,
2 I, 2. 11 | 5-12~Suhrcke M, McKee M, Sauto Arce R, Tsolova S,
3 II, 4. 3 | 403-432.~ ~Robine, J.-M. and C. Jagger (2007): Healthy
4 II, 4. 3 | Ashgate: 317-328.~ ~Robine, J.-M. and C. Jagger (2007): Strategic
5 II, 4. 3 | Montpellier, Inserm~ ~Robine, J.-M., C. Jagger, et al. (2002):
6 II, 4. 3 | 119-133.~ ~Robine, J.-M., C. Jagger, et al. (2003):
7 II, 4. 3 | 13(3): 6-14.~ ~Robine, J.-M., C. Jagger, et al., Eds. (
8 II, 4. 3 | 2003; 13:6-14.~ ~Robine, J.-M., C. Jagger, et al. (2001):
9 II, 4. 3 | 2): 89-101.~ ~Robine, J.-M., S. Le Roy, et al. (2005):
10 II, 4. 3 | EHEMU: 9-48.~ ~Robine, J.-M. and J.-P. Michel (2004):
11 II, 5. 2. 6 | Kimura N, Lekos D, Monti M, Puddu V, Taylor HL (1966).
12 II, 5. 2. 7 | Scarborough P, Peto V and Rayner M (2008): European cardiovascular
13 II, 5. 2. 7 | Tolonen H, Hense HW, Ferrario M, Sans S, Kuulasmaa K, for
14 II, 5. 2. 7 | Tolonen H, Evans A, Ferrario M, Tuomilehto J (2000): Estimation
15 II, 5. 2. 7 | C, Giampaoli S, Trojani M, Panico S, Vanuzzo D, Pilotto
16 II, 5. 2. 7 | Pilotto L, Cesana G, Ferrario M, Chiodini P, Sega R, and
17 II, 5. 2. 7 | Chiodini P, Cesana G, Ferrario M, Mattiello A, Pilotto L,
18 II, 5. 2. 7 | Petersen S, Peto V, Rayner M, Leal J, Luengo-Fernandez
19 II, 5. 2. 7 | Stegmayr B, Tolonen H, MAhonen M, Tuomilehto J, Asplund K,
20 II, 5. 2. 7 | 510-20.~Tolonen H, Mahonen M, Asplund K, rastenyte D,
21 II, 5. 2. 7 | H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E,
22 II, 5. 2. 7 | Tunstall-Pedoe H, Vanuzzo D, Hobbs M et al for the WHO MONICA
23 II, 5. 2. 7 | Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigo
24 II, 5. 3. 9 | Berrino F, De Angelis R, Sant M, Rosso S, Bielska-Lasota
25 II, 5. 3. 9 | Rosso S, Bielska-Lasota M, Coebergh JWW, Santaquilani
26 II, 5. 3. 9 | Coebergh JWW, Santaquilani M, and the EUROCARE Working
27 II, 5. 3. 9 | Verdecchia A, Estève J, Sant M, Storm H, Allemani C, Ciccolallo
28 II, 5. 3. 9 | Ciccolallo L, Santaquilani M, Berrino F, EUROCARE Working
29 II, 5. 3. 9 | Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle
30 II, 5. 3. 9 | Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007):
31 II, 5. 3. 9 | Boniol M, Heanue M, Colombet M, Boyle P (2007): Estimates
32 II, 5. 3. 9 | P, Berrino F, Terenziani M, the EUROCARE Working Group (
33 II, 5. 3. 9 | 16): 3742-3751.~ ~Hakama M, De Koning H (2007): Portuguese
34 II, 5. 3. 9 | Micheli A, Baili P, Quinn M, Mugno E, Capocaccia R,
35 II, 5. 3. 9 | Verdecchia A, Berrino F, Coleman M (2003): Cancer control in
36 II, 5. 3. 9 | Clin 55(2):74-108.~ ~Sant M, Aareleid T, Berrino F,
37 II, 5. 3. 9 | Berrino F, Bielska Lasota M, Carli P, Faivre J, Grosclaude
38 II, 5. 3. 9 | Micheli A, Santaquilani M, Roazzi P, Lisi D, EUROCARE
39 II, 5. 4. 8 | 14(2), 100-103.~Carinci M, Federici Orsini M, Massi
40 II, 5. 4. 8 | Carinci M, Federici Orsini M, Massi Benedetti M (2005),
41 II, 5. 4. 8 | Orsini M, Massi Benedetti M (2005), Diabetes registers
42 II, 5. 4. 8 | 1414-31~Massi Benedetti M, Carinci F, Orsini Federici
43 II, 5. 4. 8 | Carinci F, Orsini Federici M (2006), The Umbria Diabetes
44 II, 5. 5.Int(12)| mental health. In P. Östlin, M. Danielsson, F. Diderichsen,
45 II, 5. 5.Int(15)| MJ, Reischies F, Roelands M, Skoog I, Turrina C, deVries
46 II, 5. 5.Int(17)| Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL (
47 II, 5. 5.Int(18)| Makino M, Tsuboi K, Dennerstein L.(
48 II, 5. 5. 1 | Alonso J, Angermeyer M, Bernert S, Bru t (2004b).
49 II, 5. 5. 1 | 68(suppl 2): 3-9.~ ~Berk M, Dodd S, Henry M (2006).
50 II, 5. 5. 1 | Berk M, Dodd S, Henry M (2006). The effect of macroeconomic
51 II, 5. 5. 1 | Helsinki.~ ~Haro JM, Bernal M, Bernert S, Brugha T, de
52 II, 5. 5. 1 | 16.~ ~Ormel J, Petukhova M, Chaterji S, Agu C (2008).
53 II, 5. 5. 2 | 2008)~ ~Ferri CL, Prince M et al (2005): Global prevalence
54 II, 5. 5. 2 | December 17/24/31~ ~Godfrey M, Townsend J, Surr C, Boyle
55 II, 5. 5. 3 | References~Alexander D, Rigby M, (in press, due January
56 II, 5. 5. 3 | press.~Alexander D, Rigby M, Frazzica R.G, Sjöström
57 II, 5. 5. 3 | Frazzica R.G, Sjöström M, Hillger C, Neumann G, Kirch
58 II, 5. 5. 3 | Lohr, K. N.; Bulik, C. M. (2007): Outcomes of Eating
59 II, 5. 5. 3 | Bourdeaudhuij I, Gonzalez-Gross M, Leclercq C, Kafatos A,
60 II, 5. 5. 3 | Molnar D, Marcos A, Castillo M, Dallongeville J, Gilbert
61 II, 5. 5. 3 | Breidenasse C, Kersting M, Moreno LA, on behalf of
62 II, 5. 5. 3 | on 19 March 2008).~Gupta M A (1995): Concerns About
63 II, 5. 5. 3 | Luce KH, Crowther JH, Pole M, (2008): Eating Disorder
64 II, 5. 5. 3 | 2008-DOI 10.1002/eat.~Misra M, Aggarwal A Miller, K.K,
65 II, 5. 5. 3 | K.K, Almazan, C, Worley, M,. Soyka, L.A, Herzog, D.B,
66 II, 5. 5. 3 | Shen Y, Huang Y, Zhang M, Alonsro J, Haro JM, Vilagut
67 II, 5. 5. 3 | Engl J, Tschoner A, Laimer M, Rettenbacher M, Fleischhacker
68 II, 5. 5. 3 | Laimer M, Rettenbacher M, Fleischhacker W, Parsch
69 II, 5. 5. 3 | Klosterkötter J, Wagner M, Maier W, Bottlender R,
70 II, 5. 5. 3 | 117-28.~Healy D, Harris M, Tranter R, Gutting P, Austin
71 II, 5. 5. 3 | Fleischhacker W, Boter H, Davidson M, Vergouwe Y, Keet IPM, Gheorghe
72 II, 5. 5. 3 | Galderisi S, Libiger J, Hummer M, Dollfus S, Lopez-Ibor J,
73 II, 5. 5. 3 | RK, Linszen D, Birchwood M, Juckel G, Morrirson A,
74 II, 5. 5. 3 | Vázquèz-Barquero JL, Hambrecht M, VON Reventlow H (2005):
75 II, 5. 5. 3 | Psychiatry 4(3):161-7.~Knapp M, McDaid D, Mossialos E,
76 II, 5. 5. 3 | Burkard T, Henderson J, Maj M, Sartorius N (2007): Physical
77 II, 5. 5. 3 | 317-33.~Leucht S, Stiegler M, Rummel C, Wahlbeck K, Kissling
78 II, 5. 5. 3 | Lindström E, Eberhard J, Neovius M, Levander S (2007): Costs
79 II, 5. 5. 3 | J, Nilsson LL, Sandlund M, Sörgaard KW (2001):The
80 II, 5. 5. 3 | 191 (50): s15-s20.~Prince M, Patel V, Saxena S, Maj
81 II, 5. 5. 3 | Patel V, Saxena S, Maj M, Maselko J, Phillips MR,
82 II, 5. 5. 3 | Lancet 370(9590):810-11.~Sato M (2006): Renaming schizophrenia:
83 II, 5. 5. 3 | countries (Tuori T, Gissler M, Wahlbeck K), Section B,
84 II, 5. 5. 3 | 2005, 66 (suppl. 10)~Knapp M, Romeo R, Beecham J (2007):
85 II, 5. 5. 3 | Epilepsia 30:411-412.~Endziniene M, Pauza V, Miseviciene V (
86 II, 5. 5. 3 | Beghi E, Oun A, Sillanpaa M (2005): The epidemiology
87 II, 5. 5. 3 | Loiseau J, Loiseau P, Guyot M, et al (1990): Survey of
88 II, 5. 5. 3 | Lancet 359:1790-1791.~Rutter M, Graham P, Yule W (1970):
89 II, 5. 5. 3 | Seizure 5:139-146.~Sillanpaa M (1992): Epilepsy in children:
90 II, 5. 5. 3 | Epilepsia 33: 441-449.~Sillanpaa M, Jalava M, Kaleva O, Shinnar
91 II, 5. 5. 3 | 449.~Sillanpaa M, Jalava M, Kaleva O, Shinnar S (1998):
92 II, 5. 5. 3 | May 2005).~Van den Broek M, Beghi E, for the RESt-1
93 II, 5. 5. 3 | assistance needed to walk 20 m; 7.0 to 9.5 refers to patients
94 II, 5. 5. 3 | Hungarica 13:68-70.~Battaglia M, Kesselring J, Ketelaer
95 II, 5. 5. 3 | Favorova O, Gusev E, Sudomoina M, Turetskaya R (1995): Epidemiology
96 II, 5. 5. 3 | 253:914-918.~Dean G, Elian M, Galea de Bono A, et al (
97 II, 5. 5. 3 | Fangerau T, Schimrigk S, Haupts M, et al (2004): Diagnosis
98 II, 5. 5. 3 | Ford HL, Gerry E, Johnson M, Williams R (2002). A prospective
99 II, 5. 5. 3 | Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H (1996): Distinct
100 II, 5. 5. 3 | eaManceau E, Lucas B, Lemesle M, Urbinelli R, Giroud M (
101 II, 5. 5. 3 | Lemesle M, Urbinelli R, Giroud M (2000): Incidence of multiple
102 II, 5. 5. 3 | Lucchinetti C, Rodriguez M, Weinshenker BG (2000):
103 II, 5. 5. 3 | Health 118:268–283.~Pugliatti M, Sotgiu S, Solinas G et
104 II, 5. 5. 3 | Scand 103:20-26~Pugliatti M, Sotgiu S, Rosati G (2002):
105 II, 5. 5. 3 | Neurosurgery 104:182-191.~Pugliatti M, Riise T, Sotgiu MA, et
106 II, 5. 5. 3 | Neuroepidemiology 25:129–134.~Pugliatti M, Rosati G, Carton H, et
107 II, 5. 5. 3 | Neurol 13: 700–722.~Pugliatti M, Rosati G (in press): Epidemiology
108 II, 5. 5. 3 | Robertson NP, Deans J, Fraser M, Compston DAS (1995): multiple
109 II, 5. 5. 3 | 336.~Sobocki P, Pugliatti M, Lauer L, Kobelt G (2007):
110 II, 5. 5. 3 | Wikström J, Palo, J, Hakama M (2000): Regional and temporal
111 II, 5. 5. 3 | Wikström J, Palo, J, Hakama M (2001): Increasing prevalence
112 II, 5. 5. 3 | Sumelahti ML, Tienari PJ, Hakama M, Wikström J (2003): Multiple
113 II, 5. 5. 3 | Med 338:278-285.~Trisolini M, Wiener J, Miller D (2002):
114 II, 5. 5. 3 | Suppl 1:1-27.~Baldereschi M, Di Carlo A, Rocca WA, Vanni
115 II, 5. 5. 3 | Neuroepidemiology 20(4):225-231.~Brewis M, Poskanzer DC, Rolland C,
116 II, 5. 5. 3 | Nomos-Verlag.~Chade AR, Kasten M, Tanner CM (2006): Nongenetic
117 II, 5. 5. 3 | 10-15.~Dodel RC, Singer M, Koehne-Volland R, Szucs
118 II, 5. 5. 3 | Evers S, Obladen M (1994): Epidemiology and
119 II, 5. 5. 3 | 275.~Fall PA, Fredrikson M, Axelson O, Granérus AK (
120 II, 5. 5. 3 | 28-37.~ ~Findley L, Aujla M, Bain PG, Baker M, Beech
121 II, 5. 5. 3 | Aujla M, Bain PG, Baker M, Beech C, Bowman C, Holmes
122 II, 5. 5. 3 | 174.~Granieri E, Carreras M, Casetta I, Govoni V, Tola
123 II, 5. 5. 3 | Disord 20(2):190-199~Hoehn M, Yahr MD (1967): Parkinsonism:
124 II, 5. 5. 3 | 10(2):331-339.~Horstink M, Tolosa E, Bonuccelli U,
125 II, 5. 5. 3 | Moutard-Martin F, Dujardin M, Ziegler M (1999): Cost
126 II, 5. 5. 3 | Moutard-Martin F, Dujardin M, Ziegler M (1999): Cost of illness
127 II, 5. 5. 3 | Available at: htt f.~Quik M (2004): Smoking, nicotine
128 II, 5. 5. 3 | 394.~Spottke AE, Reuter M, Machat O, Bornschein B,
129 II, 5. 5. 3 | Kulas E, Cutson T, Schenkman M (1997): The burden of Parkinson’
130 II, 5. 6. 6 | TD, Greenwald R, Hochberg M, . (1986) Development of
131 II, 5. 6. 6 | 1377~Birnbaum HG, Barton, M, Greenberg PE, Sisitsky
132 II, 5. 6. 6 | HD, Breedveld F, Dougados M, Emery P, Ferraccioli G,
133 II, 5. 6. 6 | Croft P, Coggon D, Cruddas M, Cooper C (1992): Osteoarthritis
134 II, 5. 6. 6 | at URL: htt ~ ~Dougados M, Gueguen A, Nguyen M, Thiesce
135 II, 5. 6. 6 | Dougados M, Gueguen A, Nguyen M, Thiesce A, Listrat V, Jacob
136 II, 5. 6. 6 | JP, Gabriel KR, Lequesne M, Amor B (1992): Longitudinal
137 II, 5. 6. 6 | Rheumatol 24:1703-1709~Hakala M, Nieminen P, Koivisto O (
138 II, 5. 6. 6 | 42~Jonsson D and Husberg M (2000): Socioeconomic Costs
139 II, 5. 6. 6 | JP, Karaharju EO, Porras M, Luthje P, Jakobsson A (
140 II, 5. 6. 6 | Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL (
141 II, 5. 6. 6 | Cooper C, Finn JD, Lunt M, Purdie D, Reid DM, Rowe
142 II, 5. 6. 6 | Hart DJ, and Leedham-Green M (1991): The prevalence of
143 II, 5. 6. 6 | Bijl RV, de Boer JB, Foets M, Hoeymans N, Jacobs AE,
144 II, 5. 6. 6 | Canner R, North F, Marmot M (1995): Sickness absence
145 II, 5. 6. 6 | Asten P, Barrett E, Lunt M, Scott D, Silman A (2002):
146 II, 5. 6. 6 | Oxford) 41:793-800~Urwin M, Symmons D, Allison T, Brammah
147 II, 5. 6. 6 | Brammah T, Busby H, Roxby M, Simmons A, Williams G (
148 II, 5. 7. 7 | Gu D, Kusek JW, Spruill M, Reynolds K, et al (2005)
149 II, 5. 7. 7 | JAMA 19):2560-72.~Cirillo M, Laurenzi M, Mancini M,
150 II, 5. 7. 7 | 72.~Cirillo M, Laurenzi M, Mancini M, Zanchetti A,
151 II, 5. 7. 7 | Cirillo M, Laurenzi M, Mancini M, Zanchetti A, Lombardi C,
152 II, 5. 7. 7 | SS, Arnett D, Eigenbrodt M, Nieto FJ, et al (2002):
153 II, 5. 7. 7 | Jan;26(1):68-79.~Kurella M, Lo JC, Chertow GM (2005):
154 II, 5. 7. 7 | Jul 20.~Rodgers A, Ezzati M, Vander Hoorn S, Lopez AD,
155 II, 5. 7. 7 | Aug;21(8):2178-83.~Tonelli M, Wiebe N, Culleton B, House
156 II, 5. 7. 7 | House A, Rabbat C, Fok M, et al (2006): Chronic kidney
157 II, 5. 8. 7 | 797.~ ~Balmes J, Becklake M, Blanc P, Henneberger P,
158 II, 5. 8. 7 | Cazzoletti L, Beccaria M, Marinoni A, Viegi G, de
159 II, 5. 8. 7 | Jemal A, Lee TA, Miravitlles M, Aldington S, Beasley R (
160 II, 5. 8. 7 | Detournay B, Pribil C, Fournier M, Housset B, Huchon G, Huas
161 II, 5. 8. 7 | Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic
162 II, 5. 8. 7 | Ligabue G, Ciaccia A, Saetta M, Papi A (2003): Differences
163 II, 5. 8. 7 | Marciniuk D., Rennie D., Stang M (2008):. Health care utilization
164 II, 5. 8. 7 | 2007)~ ~Gorecka D, Bednarek M, Nowinski A, Puscinska E,
165 II, 5. 8. 7 | B, Lindberg A, Lindstrom M, Ronmark E, Jonsson AC,
166 II, 5. 8. 7 | L, Viejo JL, Miravitlles M. (2004):Costs of chronic
167 II, 5. 8. 7 | 58: 65-70.~ ~Miravitlles M, de la Roza C, Morera J,
168 II, 5. 8. 7 | 2006, Eurostat.~ ~Pelkonen M, Notkola IL, Nissinen A,
169 II, 5. 8. 7 | WM, Allison MJ, Studnicka M, Jensen RL, Buist AS (2007):
170 II, 5. 8. 7 | 1-6.~ ~Sidney S, Sorel M, Quesenberry CP Jr, DeLuise
171 II, 5. 8. 7 | Urrutia I, Payo F, Olivieri M, Villani S, Van Sprundel
172 II, 5. 8. 7 | Villani S, Van Sprundel M, Antó JM, and Kogevinas
173 II, 5. 8. 7 | Antó JM, and Kogevinas M for the Occupational Group
174 II, 5. 8. 7 | 1355.~ ~Viegi G, Pedreschi M, Pistelli F, Di Pede F,
175 II, 5. 8. 7 | Zielinski J, Bednarek M, Gorecka D, Viegi G, Hurd
176 II, 5. 8. 7 | J-P, Sunyer J, Kogevinas M, Kromhout H, Burney P, Antó
177 II, 5. 9. 4 | the male to female ratio (M:F) significantly narrowed
178 II, 5. 9. 7 | Strachan DP, Austin JB, Burr M, Jeffs D (2004): Trends
179 II, 5. 9. 7 | PJ, Hooper R, Kogevinas M, Jarvis D, Burney P. (2007a): Nu I.
180 II, 5. 9. 7 | Chinn S, Janson C, Kogevinas M, Burney P, Jarvis D (2007b): Ge I.
181 II, 5. 9. 7 | Allergy, 37, 788–79~ ~Bugiani M (2005): Allergic rhinitis
182 II, 5. 9. 7 | 960~ ~Compalati E, Penagos M, Henley K, Canonica GW (
183 II, 5. 9. 7 | Aug;110(2):228-35~ ~Duse M (2007): High prevalence
184 II, 5. 9. 7 | Fasce L, Tosca MA, Silvestri M, Olcese R, Pistorio A, Rossi
185 II, 5. 9. 7 | prevention. Revised 2006~ ~Masoli M, Fabian D, Holt S, Beasley
186 II, 5. 9. 7 | 2007; 62:293-300~ ~Osman M (2007): Changing trends
187 II, 5. 10. 7 | Dubakiene R, Fernandez-Rivas M, Hoffmann-Sommergruber K,
188 II, 5. 10. 7 | Hourihane JO, Kowalski M, Papadopoulos NG, Wal JM,
189 II, 5. 10. 7 | 147.~ ~Brusic V, Millot M, Petrovsky N, Gendel SM,
190 II, 5. 10. 7 | Allergy 32: 373-378.~Løvik M and Namork N (2004): The
191 II, 5. 10. 7 | series, pp. 41.~ ~Stern M, Ciclitira PJ, Van Eckert
192 II, 5. 10. 7 | 9.~ ~Woods RK, Abramson M, Raven JM, Bailey M, Weiner
193 II, 5. 10. 7 | Abramson M, Raven JM, Bailey M, Weiner JM, Walters EH et
194 II, 5. 10. 7 | 155.~ ~Woods RK, Abramson M, Bailey M, Walters EH. International
195 II, 5. 10. 7 | Woods RK, Abramson M, Bailey M, Walters EH. International
196 II, 5. 10. 7 | J, Walters EH, Abramson M, Thien FC (2002): Reported
197 II, 5. 11. 3 | at 2 yrs of age=7%~Böhme M, et al~ ~Swedish school
198 II, 5. 11. 3 | prevalence=10%~Yngveson M, et al~ ~Danish school children
199 II, 5. 11. 3 | incidence=2.1%)~Radulescu M, et al~ ~Source: Modified
200 II, 5. 11. 3 | 146:636–642.~LM Koenig, M Carnes, Body Piercing. Medical
201 II, 5. 11. 3 | 1985;13:289–293.~C Lidén, M Bruze, T Menné, Chapter
202 II, 5. 11. 3 | 1999;41:121-130.~T Nakada, M Iijima, H Nakayama, HI Maibach,
203 II, 5. 11. 3 | E Silva, A Barr , M Gonç , T Corr a, G Pessoa,
204 II, 5. 11. 3 | G Pessoa, A Bapt a, M Pece o, Contact allergy
205 II, 5. 11. 7 | 11.7. References~ ~Böhme M, Svensson Å, et al (2001):
206 II, 5. 11. 7 | 1):5-6.~ ~Boyle P, Smans M (2003): Cancer Mortality
207 II, 5. 11. 7 | 24.~ ~Wassberg C, Thorn M, Johansson AM et al (2001):
208 II, 5. 12. 7 | Ortolani G, Adamo B, Rapicetta M, Forte P,~Pisani A, Soldo
209 II, 5. 12. 7 | Sanchez-Hernandez E, Rivero M, Vergara M, Martin -~ ~Ioannou
210 II, 5. 12. 7 | Sanchez-Hernandez E, Rivero M, Vergara M, Martin -~ ~Ioannou G, Doust
211 II, 5. 12. 7 | Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi
212 II, 5. 12. 7 | Poynard T, Naveau S, Doffoel M, Boudjema K, Vanlemmens
213 II, 5. 12. 7 | Vanlemmens C, Mantion G, Messner M, Launois B, Samuel D, Cherqui
214 II, 5. 12. 7 | 30:1130-1137.~ ~Ramstedt M (2001): Per capita alcohol
215 II, 5. 15. 6 | accessed 15.05.2007)~Wastfelt M, Fadeel B, Henter JI. A
216 II, 7. 7 | Bauer R, Nossek G, Steiner M (2007): Freizeitunfallstatistik
217 II, 7. 7 | 2008]).~ ~Holder Y, Peden M, Krug E (Eds.) (2001): Injury
218 II, 7. 7 | Road Safety Board.~ ~MacKay M, Vincenten J, Brussoni M,
219 II, 7. 7 | M, Vincenten J, Brussoni M, Towner L (2006): Child
220 II, 7. 7 | Alliance, EuroSafe.~ ~MacKay M and Vincenten J (2007):
221 II, 7. 7 | Health Organization, Peden M, McGee K, Sharma G.~ ~Racioppi
222 II, 8. 2. 1 | Lachapelle, Y., Reeve, A., Snell, M.E., Spreat, S., Tasse, M.
223 II, 8. 2. 1 | M.E., Spreat, S., Tasse, M.J., Thompson, J.R., Verdugo,
224 II, 8. 2. 1 | Verdugo, M-A, Wehmeyer, M.L. and Yeager, M.H. (2007).
225 II, 8. 2. 1 | Wehmeyer, M.L. and Yeager, M.H. (2007). The Renaming
226 II, 8. 2. 1 | Dentistry 4, 321-325.~Scheepers M, Kerr M, O’Hara D, Bainbridge
227 II, 8. 2. 1 | 321-325.~Scheepers M, Kerr M, O’Hara D, Bainbridge D,
228 II, 8. 2. 1 | Lennox N, Meaney J & Wehmeyer M (2005). Reducing health
229 II, 8. 2. 1 | 249-55.~Straetmans, J.M.J.A.A., H.M.J. van Schrojenstein
230 II, 8. 2. 1 | Straetmans, J.M.J.A.A., H.M.J. van Schrojenstein Lantman-de
231 II, 8. 2. 1 | P.N., Linehan, C., Kerr, M., van Schrojenstein Lantman-de
232 II, 8. 2. 1 | Salvador-Carulla, L., Garrido-Cumbrera, M., van Hove, G., Björkman,
233 II, 8. 2. 1 | van Hove, G., Björkman, M., Ceccotto, R., Kamper,
234 II, 8. 2. 1 | Ceccotto, R., Kamper, M., Weber, G., Heiss, C.,
235 II, 8. 2. 1 | G., Heiss, C., Haveman, M., Jørgensen, F., & O’Farrell,
236 II, 8. 2. 2 | Stewart NM and Hollinger M. (2005): Prevalence and
237 II, 8. 2. 2 | Culasso F, Ricci F, Cesareo M, Corsi A and Cerulli L. (
238 II, 8. 2. 3 | Mathers C, Smith A, Concha M (2003): Global burden of
239 II, 8. 2. 3 | Jounio-Ervasti K, Sorri M (1999): Do we know the real
240 II, 9. 1. 1 | Wildman K, Zhang W, Langer M, Vutuc C, Lindmark G (2003):
241 II, 9. 1. 1 | Wong FW, Bauman A, Mohsin M (2002): Parity and pregnancy
242 II, 9. 1. 1 | B, Macfarlane A, Gissler M, Breart G, Zeitlin J (2006):
243 II, 9. 1. 1 | 1989;321(4):233-9.~ ~Hansen M, Kurinczuk JJ, Bower C,
244 II, 9. 1. 1 | 102(4):685-92.~Kaminski M, Blondel B, Saurel-Cubizolles
245 II, 9. 1. 1 | Johnson A, Surman G, Topp M, Torrioli MG, et al (2007):
246 II, 9. 1. 1 | 369(9555):43-50.~Prysak M, Lorenz RP, Kisly A (1995):
247 II, 9. 1. 1 | Reddy UM, Ko CW, Willinger M (2006): Maternal age and
248 II, 9. 1. 1 | E, Knudsen L, Levasseur M, Schenker J, et al (1993):~
249 II, 9. 1. 1 | Gortner L, Milligan D, Cuttini M, Petrou S, Agostino R, et
250 II, 9. 1. 2 | H, Armstrong N, Haeusler M, Berghold A, Gillerot Y,
251 II, 9. 1. 2 | Barisic I, Christiansen M, Goujard J, Steinbicker
252 II, 9. 1. 2 | Cocchi G, Bianca S, Gatt M, de Walle H, Braz P, Latos-Bielenska
253 II, 9. 1. 2 | Walle H, Riano-Galan I, Gatt M, McDonnell R, Nelen V and
254 II, 9. 1. 2 | 357: 135-42.~Dolk H, Loane M, Garne E, de Walle, H, Queisser-LuftA,
255 II, 9. 1. 2 | Addor M-C, Gener B, Haeusler M, Jordan H, Tucker D, Stoll
256 II, 9. 1. 2 | Tucker D, Stoll C, Feijoo M, Lillis D, Bianchi F (2005): "
257 II, 9. 1. 2 | Walle H, Garne E, Loane M, Pierini A, Garcia-Minaur
258 II, 9. 1. 2 | 398-402.~Dolk H, Vrijheid M (2003): "The Impact of Environmental
259 II, 9. 1. 2 | pp 52-58.~Garne E, Loane M, Nelen V, Bakker M, Gener
260 II, 9. 1. 2 | Loane M, Nelen V, Bakker M, Gener B, Abramsky L, Addor
261 II, 9. 1. 2 | 165-169.~Garne E, Loane M, Dolk H, de Vigan C, Scarano
262 II, 9. 1. 2 | pp 6-11.~Garne E, Loane M, de Vigan C et al (2004): “
263 II, 9. 1. 2 | 2004; Vol 8, no. 33.~Hansen M, Bower C, Milne E, de Klerk
264 II, 9. 1. 2 | Reprod 2005; 20:328-38.~Loane M, Dolk H, Bradbury and a
265 II, 9. 1. 2 | H, McElhatton P, Reuvers M, Robert E, Rost van Tonningen
266 II, 9. 1. 2 | Robert E, Rost van Tonningen M, Scialli A, Peters P (2001):
267 II, 9. 1. 2 | Elsevier 2001.~Vrijheid M, Dolk H, Stone D, Abramsky
268 II, 9. 2. 7 | References~ ~Alexander D, Rigby M, Hillger C, Neumann G, Kirch
269 II, 9. 2. 7 | Brussels.~ ~De Smedt, M. (2004): Towards A Common
270 II, 9. 2. 7 | Heuveline P., Timberlake J.M. (2000): Toward A Child-Centered
271 II, 9. 2. 7 | Cancer. 37:785-809.~ ~Masoli M, Fabian D, Holt S, Beasley
272 II, 9. 2. 7 | Neumark-Sztainer D; Wall M; Story M; Fulkerson JA. (
273 II, 9. 2. 7 | Neumark-Sztainer D; Wall M; Story M; Fulkerson JA. (2004): Are
274 II, 9. 2. 7 | 01.07)~ ~Ståhl T, Wismar M, Ollila E, Lahtinen E, Leppo
275 II, 9. 3. 1 | Robertson, C. Mazzeha, C. Keech. M. Hobbs, F.D.R. Fourcade
276 II, 9. 3. 1 | Treatment 14: 256-262~ ~Braun, M., Wassner, G Klotz, T Reifenrath,
277 II, 9. 3. 1 | T Reifenrath, B Mathers, M Engleman, U (2000) Epidemiology
278 II, 9. 3. 1 | 07.07)~ ~Britton A McKee M (2000): The relation between
279 II, 9. 3. 1 | p. 921 - 931.~ ~De Smedt M (2004): Towards A Common
280 II, 9. 3. 1 | Fenton K A and Lowndes C M (2004): Recent trends in
281 II, 9. 3. 1 | Beghi E, Õun A, Sillanpää M (2005): The epidemiology
282 II, 9. 3. 1 | IN White, A & Pettifer, M (eds) Hazardous Waist: tackling
283 II, 9. 3. 1 | 20): p. 1516-23~ ~Makino M, Tsuboi K, Dennerstein L (
284 II, 9. 3. 1 | 94 – 7~ ~White AK, Holmes M, (2006): Patterns of mortality
285 II, 9. 3. 2 | Wildman K, Zhang W, Langer M, Vutuc C, Lindmark G (2003):
286 II, 9. 3. 2 | Wong FW, Bauman A, Mohsin M (2002): Parity and pregnancy
287 II, 9. 3. 2 | B, Macfarlane A, Gissler M, Breart G, Zeitlin J (2006):
288 II, 9. 3. 2 | 1989;321(4):233-9.~ ~Hansen M, Kurinczuk JJ, Bower C,
289 II, 9. 3. 2 | 102(4):685-92.~ ~Kaminski M, Blondel B, Saurel-Cubizolles
290 II, 9. 3. 2 | 89(3):451-7.~ ~Philibert M, Boisbras F, Bouvier-Colle
291 II, 9. 3. 2 | Johnson A, Surman G, Topp M, Torrioli MG, et al (2007):
292 II, 9. 3. 2 | 369(9555):43-50.~ ~Prysak M, Lorenz RP, Kisly A (1995):
293 II, 9. 3. 2 | Reddy UM, Ko CW, Willinger M (2006): Maternal age and
294 II, 9. 3. 2 | E, Knudsen L, Levasseur M, Schenker J, et al (1993):~ ~
295 II, 9. 3. 2 | 12):816-24.~ ~Temmerman M, Foster LB, Hannaford P,
296 II, 9. 3. 2 | Gortner L, Milligan D, Cuttini M, Petrou S, Agostino R, et
297 II, 9. 3. 3 | 18-49 age group (Hubert M et al, 1998).~· Global sex
298 II, 9. 3. 3 | group 13-19 years (Imamura M et al, 2007).~· Information
299 II, 9. 3. 3 | 42.~Beltzer N, Lagarde M, Wu Zhou X, Vongmany N,
300 II, 9. 3. 3 | d’Ile de France.~Bochow M, Chiarotti F, davies P,
301 II, 9. 3. 3 | Care 6(5) :533-49.~Bozon M, Kontula O (1998): Sexual
302 II, 9. 3. 3 | surveys. (Edited by:Hubert M, Bajos N, Sandroft T) London:
303 II, 9. 3. 3 | BZgA, 124 p. htt de~Hubert M, Bajos N, Sandroft T (1998)
304 II, 9. 3. 3 | London. 442 p.~Imamura M, Tucker J, Hannaford P,
305 II, 9. 3. 3 | Hannaford P, da Silva MO, Astin M, Wyness L, Bloemenkamp KWM,
306 II, 9. 3. 3 | Karro H, Olsen J, Temmerman M on behalf of the REPROSTAT
307 II, 9. 3. 3 | Lancet 366:1141-42.~Nikula M, Kaponen P, Haavio-Mannila
308 II, 9. 3. 3 | Serbanescu F, Morris L, Marin M (2001): Reproductive health
309 II, 9. 3. 3 | Limina RM, Cozani E, Fanti M, Cielo A, Greco M, de Somenzi
310 II, 9. 3. 3 | Fanti M, Cielo A, Greco M, de Somenzi CP, Chironna
311 II, 9. 3. 3 | de Somenzi CP, Chironna M, Quarto M (2006): Third
312 II, 9. 3. 3 | Somenzi CP, Chironna M, Quarto M (2006): Third Italian national
313 II, 9. 3. 3 | Wellings K, Collumbien M, Slaymaker E, Singh S, Hodges
314 II, 9. 4. 7 | De Henauw S., Schroll M., Van Staveren Wa. (2004):
315 II, 9. 5. 6 | Princeton University~ ~Denton M, Prus S, Walter V (2004):
316 II, 9. 5. 6 | 12):2585-2600~ ~De Smedt M, (2004): Towards A Common
317 II, 9. 5. 6 | 2 October 1998~ ~Eichler M, Burke M A (2006): The BIAS
318 II, 9. 5. 6 | 1998~ ~Eichler M, Burke M A (2006): The BIAS FREE
319 II, 9. 5. 6 | by Östlin P, Danielsson M, Diderichsen F, Härenstam
320 II, 9. 5. 6 | Parliament, Brussels.~ ~Jarvis M J (2004): Why People Smoke.
321 II, 9. 5. 6 | 07.07)~ ~Klinge I, Bosch M (2005): State of the Art –
322 II, 9. 5. 6 | Development; 22(1): 55-71~ ~Morris M (2004): 'What research reveals
323 II, 9. 5. 6 | 1596~ ~White AK, Holmes M (2006): Patterns of morbidity
324 III, 10. 1. 3 | Roland EJ, Moore-Gurrera M (1997): Issues in the linkage
325 III, 10. 1. 3 | Dahlgren, G. & Whitehead, M. (1991): Policies and Strategies
326 III, 10. 1. 3 | Report No 10/2005~Ezzati M, Lopez AD, Rodgers A, Hoorn
327 III, 10. 1. 3 | CS, Solorzano R, Kelley M, Darrow V, Gendrop SC, Strickland
328 III, 10. 1. 3 | Psychiatr Scand 113:13-22.~Szklo M (2000): Confounding and
329 III, 10. 1. 3 | Dermatol 136(12):1544-6.~Szklo M, Nieto J (2005): Epidemiology
330 III, 10. 2. 1 | Fagerström K, Jarvis MJ, Kunze M, McNeill A, Ramström L (
331 III, 10. 2. 1 | Christensen L, Denis L, Dicato M, Diehl L, Doll R, Franceschi
332 III, 10. 2. 1 | Griciute L, Hackshaw A, Kasler M, Kogevinas M, Kvinnsland
333 III, 10. 2. 1 | Hackshaw A, Kasler M, Kogevinas M, Kvinnsland S, La Vecchia
334 III, 10. 2. 1 | Oleari F, Perrin P, Quinn M, Richards M, Ringborg U,
335 III, 10. 2. 1 | Perrin P, Quinn M, Richards M, Ringborg U, Scully C, Siracka
336 III, 10. 2. 1 | Siracka E, Storm H, Tubiana M, Tursz T, Veronesi U, Wald
337 III, 10. 2. 1 | Antó JM, Cerveri I, Kerhof M, Leynaert B, Luczynska C,
338 III, 10. 2. 1 | Neukirch F, Vermeire P, Wjst M and Burney P (2006): Changes
339 III, 10. 2. 1 | 517-524~ ~Joossens L, Raw M (2008): Progress in tobacco
340 III, 10. 2. 1 | Journal, 2007; 4:17~ ~McKee M, Gilmore A (2007): Commentary -
341 III, 10. 2. 1 | Lopez AD, Boreham J, Thun M (2005) Mortality From Smoking
342 III, 10. 2. 1 | C-429/02.~ ~Jones L, James M, Jefferson T, Lushey C,
343 III, 10. 2. 1 | Jefferson T, Lushey C, Morleo M, Stokes E, Sumnall H, Witty
344 III, 10. 2. 1 | Sumnall H, Witty K, Bellis M (2007): A review of the
345 III, 10. 2. 1 | Available at: htt ~ ~Farrell, M. (1995) Drug prevention:
346 III, 10. 2. 1 | Seppa L, Cochran JA, Polido M, Athanossouli T, Holbrook
347 III, 10. 2. 1 | Pediatrics, ,117(2):417-424.Harro M et al. (2006): Monitoring
348 III, 10. 2. 1 | 26:857-865.~ ~Popkin B M, Duffey K, Gordon-Larsen
349 III, 10. 2. 1 | Trends, 2002:2–5.~ ~Pratt M, Macera CA, Blanton C (1999):
350 III, 10. 2. 1 | S526-S533.~ ~Sjöström M et al. (2006): Health-enhancing
351 III, 10. 2. 1 | Dietary-history~28~Mensink G B M et.al. (2004) Food and nutrient
352 III, 10. 2. 1 | Szponar L., Sekula W., Nelson M., Weisell R.C.: The Household
353 III, 10. 2. 1 | record~7~Becker W, Pearson M. Riksmaten 1997-98. Dietary
354 III, 10. 2. 1 | Serra-Majem L, Foz-Sala M, Moreno-Esteban B, for the
355 III, 10. 2. 1 | 675.~ ~Asciak RP, Dalmas M, Gatt M, Muscat NA, Calleja
356 III, 10. 2. 1 | Asciak RP, Dalmas M, Gatt M, Muscat NA, Calleja N (2003):
357 III, 10. 2. 1 | Camolas J, Vieira J, Carreira M, Medina L, Reis L, Galvão-Teles
358 III, 10. 2. 1 | pdf]~ ~Ekholm O, Kjøller M, Davidsen M, Hesse U, Eriksen
359 III, 10. 2. 1 | Ekholm O, Kjøller M, Davidsen M, Hesse U, Eriksen L, Christensen
360 III, 10. 2. 1 | Christensen AL, Grønbæk M (2006): Sundhed og sygelighed
361 III, 10. 2. 1 | SA, Doherty A, Trabulsi M, Speer KL (2003): Accuracy
362 III, 10. 2. 1 | C, Kalamara E, Shayeghi M, Rigby NJ, Nishida C, Rodgers
363 III, 10. 2. 1 | Vol. 1. (Edited by: Ezzati M, Lopez AD, Rodgers A, Murray
364 III, 10. 2. 1 | Bakatselos S, Kaklamanou M, Loannidis L, Lanaras L,
365 III, 10. 2. 1 | Bakatselos S, Kaklamanou M, Lanaras L, Kaklamanos I (
366 III, 10. 2. 1 | 338.~ ~Katz DL, O’Connell M, Yeh MC, Nawaz H, Njike
367 III, 10. 2. 1 | Sixsmith J, Walsh O, Cooke M (2003): The national health &
368 III, 10. 2. 1 | Ruiz JR, González-Gross M, Sarría A, Marcos A, Bueno
369 III, 10. 2. 1 | Sarría A, Marcos A, Bueno M, for the AVENA study group (
370 III, 10. 2. 1 | I, Bonenfant S, Goldberg M, Leclerc A (2000): Validity
371 III, 10. 2. 1 | Burke SJ, Hannon EM, Kiely M, Flynn A, Flynn MA, Gibney
372 III, 10. 2. 1 | Wietlisbach V, Rickenbach M (2001): Body mass index:
373 III, 10. 2. 1 | Kourides Y, Tornaritis M, Epiphaniou-Savva M, Chadjigeorgiou
374 III, 10. 2. 1 | Tornaritis M, Epiphaniou-Savva M, Chadjigeorgiou C, Kafatos
375 III, 10. 2. 1 | Savva SC, Tornaritis M, Chadjigeorgiou C, Kourides
376 III, 10. 2. 1 | Rychlik E, Oltarzewski M, Figurska K.): Warsaw, Prace
377 III, 10. 2. 1 | Polish).~ ~Tedstone A, Aviles M, Shetty P, Daniels L (1998):
378 III, 10. 2. 1 | deficiencies~ ~Andersson M, de Benoist B, Darnton-Hill
379 III, 10. 2. 1 | Pocketbooks Collection.~ ~Gurr, M. (1998). Healthy lifestyles.
380 III, 10. 2. 1 | Clavel-Chapelon F, Linseisen J, Schulz M, Hemon B, Riboli E (2002):
381 III, 10. 2. 1 | Linseisen J, Haftenberger M, Lagiou P, Kalapothaki V,
382 III, 10. 2. 1 | Kesse E, Miller AB, Schulz M, Botsi K, Naska A, Sieri
383 III, 10. 2. 1 | Ocke MC, Skeie G, Kumle M, Dorronsoro Iraeta M, Morote
384 III, 10. 2. 1 | Kumle M, Dorronsoro Iraeta M, Morote Gomez P, Janzon
385 III, 10. 2. 1 | Gonzalez CA, Dorronsoro Iraeta M, Morote Gomez P, Chirlaque
386 III, 10. 2. 1 | Sacerdote C, Del Pezzo M, Bueno-de-Mesquita HB, Ocke
387 III, 10. 2. 1 | Miller AB, Boeing H, Kolyva M, Saieva C, Celentano E,
388 III, 10. 2. 1 | MC, Peeters PH, Brustad M, Kumle M, Dorronsoro M,
389 III, 10. 2. 1 | Peeters PH, Brustad M, Kumle M, Dorronsoro M, Fernandez
390 III, 10. 2. 1 | Brustad M, Kumle M, Dorronsoro M, Fernandez Feito A, Mattisson
391 III, 10. 2. 1 | E, Amiano P, Dorronsoro M, Brustad M, Kumle M, Rodriguez
392 III, 10. 2. 1 | P, Dorronsoro M, Brustad M, Kumle M, Rodriguez M, Lasheras
393 III, 10. 2. 1 | Dorronsoro M, Brustad M, Kumle M, Rodriguez M, Lasheras C,
394 III, 10. 2. 1 | Brustad M, Kumle M, Rodriguez M, Lasheras C, Janzon L, Jansson
395 III, 10. 2. 4 | Hoffmann K., Mattheisen M, Dahm S, Nürnberg P, Roe
396 III, 10. 2. 4 | Kallioniemi A, Barlund M, Schraml P, Leighton S,
397 III, 10. 2. 4 | Lehmann DJ, Cortina-Borja M, Warden DR, Smith D, Sleegens
398 III, 10. 2. 4 | Sullivan P, Joyce P, Kennedy M (2000):, Rapid and comprehensive
399 III, 10. 2. 4 | Armstrong B, Cozen W, Linet M, Bosch FX, Ennas MG, Holford
400 III, 10. 2. 4 | Zhang Y, Severson RK, Yeager M, Chanock S, Nieters A (2006):
401 III, 10. 2. 4 | Kononen J, Haas P, Zuber M, Köchli OR, Mross F, Dieterich
402 III, 10. 2. 4 | Dieterich H, Moch H, Mihatsch M, Kallioniemi OP, Sauter
403 III, 10. 2. 4 | I, Wolf O, Gómez-Barbero M, Stein A J, Bock A K (2007):
404 III, 10. 2. 5 | References~Allen JP, Porter M, McFarland C (2007): The
405 III, 10. 2. 5 | Bastra L, Hadders-Algra M, Neeleman J (2003): Effect
406 III, 10. 2. 5 | 68:253-61.~ ~Indredavik M, Brubakk AM, Romundstad
407 III, 10. 2. 5 | 2007;48:1042-50.~ ~Mäntymaa M, Puura K, Luoma I, Salmelin
408 III, 10. 3. 1 | R, Forastiere F, Hakama M, Heid I, Kreienbrock L,
409 III, 10. 3. 1 | Kreienbrock L, Kreuzer M, Lagarde F, Mäkeläinen I,
410 III, 10. 3. 1 | Schaffrath Rosario A, Tirmarche M, Tomáek L, Whitley E, Wichmann
411 III, 10. 3. 1 | Billon S, Bergot D, Tirmarche M, Caër S, Quesne B, Laurier
412 III, 10. 3. 1 | at night. Edited by: Berg M van den. World Health Organization
413 III, 10. 3. 2 | gemeinnützige GmbH.~ ~Moldovan, M, MA Palacios, MM Gomez,
414 III, 10. 3. 2 | Petrucci, B Bocca, P Schramel, M Zischka, C Pettersson, U
415 III, 10. 3. 2 | Zischka, C Pettersson, U Wass, M Luna, JC Saenz, J Santamaria (
416 III, 10. 4. 1 | December 2005.~ ~Holland, M.,Hurley, F., Pye S., Watkiss
417 III, 10. 4. 3 | Available at: htt r/~Vahter M, et al (2006): Arsenic –
418 III, 10. 5. 1 | Norback D, Tao J, Mi YL, Ferm M, (2000) Current asthma and
419 III, 10. 5. 1 | BusAvailable at: htt ~ ~Simoni M, Viegi G, Canciani M, Sestini
420 III, 10. 5. 1 | Simoni M, Viegi G, Canciani M, Sestini P (2006): La qualità
421 III, 10. 5. 2 | Reilly G, O'Reilly D, Rosato M, Connolly S (2007): Urban
422 III, 10. 5. 3 | Gray A, Peterson S, Rayner M (2005): Economic burden
423 III, 10. 5. 3 | employment. In Siegrist J & M. Marmot (Eds.), Social Inequalities
424 III, 10. 6. 1 | Justice 30: 417-427.~ ~Beaudet M (1996). Depression. Health
425 III, 10. 6. 1 | Currie D, Picket W, Richter M, Morgan A, Barnekow V (Eds.).
426 III, 10. 6. 1 | Netherlands, 1985.~ ~Kohb M, Künemund H, Lüdicke J. (
427 III, 10. 6. 2 | Dahlgren, G. & Whitehead, M. (1991). Policies and Strategies
428 IV, 11. 6. 5 | Communities.~ ~Balabanova D, McKee M (2002): "Understanding informal
429 IV, 11. 6. 5 | Health.~ ~Blendon R, Kim M, Benson JM (2001): "The
430 IV, 11. 6. 5 | Busse R, Orvain J, Velasco M, Perleth M, Drummond M,
431 IV, 11. 6. 5 | Orvain J, Velasco M, Perleth M, Drummond M, Gürtner F,
432 IV, 11. 6. 5 | Velasco M, Perleth M, Drummond M, Gürtner F, Jørgensen T,
433 IV, 11. 6. 5 | 16(4): 1050-60.~ ~Gemmill M, Thomson S et al. (forthcoming): "
434 IV, 11. 6. 5 | Prentice Hall.~ ~Goddard M, Smith P (2001): "Equity
435 IV, 11. 6. 5 | Commonwealth Fund.~ ~Goldman M, Wood K (2007): European
436 IV, 11. 6. 5 | S1): i45-i50.~ ~Marshall M, Harrison S (2005): "It'
437 IV, 11. 6. 5 | Fund.~ ~McDaid D, Knapp M et al. (2005): Mental health
438 IV, 11. 6. 5 | Ageing 29: 249-253.~ ~McKee M, Healy J (2002): Hospitals
439 IV, 11. 6. 5 | Publishing.~ ~Merkel B, Hübel M (1999): Public Health Policy
440 IV, 11. 6. 5 | Aldershot.~ ~Mossialos E, Mrazek M et al. (2004): Regulating
441 IV, 11. 6. 5 | in Europe. E. Mossialos, M. Mrazek and T. Walley. Maidenhead,
442 IV, 11. 6. 5 | Mossialos, T. Walley and M. Mrazek. Copenhagen, WHO
443 IV, 11. 6. 5 | Research 5(1): 81-93.~ ~Mrazek M, Mossialos E (2004): Regulating
444 IV, 11. 6. 5 | and quality. E. Mossialos, M. Mrazek and T. Walley. Copenhagen,
445 IV, 11. 6. 5 | development.~ ~Nolte E, McKee M (2005): Does Health Care
446 IV, 11. 6. 5 | Management 16: 229-41.~ ~Pauly M (1968): "The econonimcs
447 IV, 11. 6. 5 | Review 58: 531-537.~ ~Perleth M, Jakubowski E et al. (2001): "
448 IV, 11. 6. 5 | 50.~ ~ ~Preker AS, Jakab M et al. (2002): Health financing
449 IV, 11. 6. 5 | in Europe. E. Mossialos, M. Mrazek and T. Walley. Maidenhead,
450 IV, 11. 6. 5 | Zentner A, Valasco-Garrido M et al., (2005): "Methods
451 IV, 12. 10 | grades in compulsory school (m)~Domain of objective 3~ ~
452 IV, 13. 9 | movement of such data.~Ezzati M, Lopez AD, Rodgers A, Hoorn
453 IV, 13. 9 | Available at: htt l.~Rigby M, Köhler L (editors) (2002):
|
|
| |
